Brandon Zhou

University of Pennsylvania — United States

Medicine · Health Sciences

1h-index29citations44works0.02yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Advanced Breast Cancer Therapies(34), Cancer-related Molecular Pathways(2), HER2/EGFR in Cancer Research(2), Chronic Lymphocytic Leukemia Research(2), T-cell and B-cell Immunology(1)

Publications44 total

Early Dendritic Cell Depletion Drives High Endothelial Venule Dysfunction and Failure of Naïve Lymphocyte Trafficking in Lymph Node Graft-Versus-Host Disease

Transplantation and Cellular Therapy·2026

Table S6 from Breast Cancer Mutations HER2V777L and PIK3CAH1047R Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance

2025Open Access

Table S5 from Breast Cancer Mutations HER2V777L and PIK3CAH1047R Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance

2025Open Access

Table S2 from Breast Cancer Mutations HER2V777L and PIK3CAH1047R Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance

2025Open Access

Figures S1-S8 from Breast Cancer Mutations HER2V777L and PIK3CAH1047R Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance

2025Open Access

Table S3 from Breast Cancer Mutations HER2V777L and PIK3CAH1047R Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance

2025Open Access

Table S4 from Breast Cancer Mutations HER2V777L and PIK3CAH1047R Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance

2025Open Access

Table S1 from Breast Cancer Mutations HER2V777L and PIK3CAH1047R Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance

2025Open Access

Cerebellum metastasis model of HER2-positive breast cancer unveils key role of IL34-induced Arg1+ macrophages

2025Open Access

Abstract 2634: IL34-induced Arg1 positive macrophage cells at the edge of invasion in cerebellum metastasis model of HER2-positive breast cancer

Cancer Research·2025

Table S6 from Breast cancer mutations HER2 V777L and PIK3CA H1047R activate the p21-CDK4/6 –Cyclin D1 axis driving tumorigenesis and drug resistance.

2024Open Access

Table S2 from Breast cancer mutations HER2 V777L and PIK3CA H1047R activate the p21-CDK4/6 –Cyclin D1 axis driving tumorigenesis and drug resistance.

2024Open Access

Data from Breast cancer mutations HER2 V777L and PIK3CA H1047R activate the p21-CDK4/6 –Cyclin D1 axis driving tumorigenesis and drug resistance.

2024Open Access

Table S4 from Breast cancer mutations HER2 V777L and PIK3CA H1047R activate the p21-CDK4/6 –Cyclin D1 axis driving tumorigenesis and drug resistance.

2024Open Access

Table S1 from Breast cancer mutations HER2 V777L and PIK3CA H1047R activate the p21-CDK4/6 –Cyclin D1 axis driving tumorigenesis and drug resistance.

2024Open Access

Table S3 from Breast cancer mutations HER2 V777L and PIK3CA H1047R activate the p21-CDK4/6 –Cyclin D1 axis driving tumorigenesis and drug resistance.

2024Open Access

Table S6 from Breast cancer mutations HER2 V777L and PIK3CA H1047R activate the p21-CDK4/6 –Cyclin D1 axis driving tumorigenesis and drug resistance.

2024Open Access

Figures S1-S8 from Breast cancer mutations HER2 V777L and PIK3CA H1047R activate the p21-CDK4/6 –Cyclin D1 axis driving tumorigenesis and drug resistance.

2024Open Access

Table S5 from Breast cancer mutations HER2 V777L and PIK3CA H1047R activate the p21-CDK4/6 –Cyclin D1 axis driving tumorigenesis and drug resistance.

2024Open Access

Table S3 from Breast cancer mutations HER2 V777L and PIK3CA H1047R activate the p21-CDK4/6 –Cyclin D1 axis driving tumorigenesis and drug resistance.

2024Open Access

page 1 of 3Next →

Frequent Co-authors

Xiaoqing Cheng(43), Maureen Highkin(43), Julie L. Prior(43), Ian S. Hagemann(43), Ron Bose(43), Xiaohua Jin(42), Nagalaxmi Vemalapally(41), Shunqiang Li(41), Anton Iliuk(41), Samuel Achilefu(41), Yirui Sun(39), Ashley R. Tipton(39), John R. Edwards(39), Keyur Patel(2), Yiwei Fu(2), Ryan Cleary(2), Jacob Hsia(2), Megan S. Michie(2), Rui Sun(2), Tristan Li(2)